Articles related to FDA

Stay abreast of the latest developments in patient care. Learn more about the FDA’s recent warning on the potential risks associated with compounded ketamine products used for treating psychiatric disorders.

Stay informed about the latest research on factors influencing COVID-19 outcomes. Learn more about how these findings could influence your approach to patient care.

Stay informed about recent recalls to ensure patient safety. Learn more about the recall of a blood pressure medication contaminated with oxycodone.

The FDA’s recent approval of Pombiliti + Opfolda just expanded treatment options for the rare inherited lysosomal disorder.

Discover how the FDA-approved Invitae’s Common Hereditary Cancers Panel can enhance your approach to early cancer detection and personalized treatment planning.

The FDA’s recent concerns about NurOwn’s efficacy and manufacturing consistency could have far-reaching implications for the future of ALS treatment. Stay updated as the agency’s final decision is expected in December.